Welcome to HI³
Canadian Hub for Health Intelligence & Innovation in Infectious Diseases
The Canadian Hub in Health Intelligence and Innovation in Infectious Diseases is a coalition of over 90 academic, hospital, research networks, industry, government, not-for-profit, and community partners with a mission to collaboratively bolster Canada's biomanufacturing capacity to ensure a fast and coordinated response to future pandemics and infectious health threats.
HI³ is one of five national hubs established through the Canada Biomedical Research Fund (CBRF).
Welcome to HI³
Canadian Hub for Health Intelligence & Innovation in Infectious Diseases
The Canadian Hub in Health Intelligence and Innovation in Infectious Diseases is a coalition of over 90 academic, hospital, research networks, industry, government, not-for-profit, and community partners with a mission to collaboratively bolster Canada's biomanufacturing capacity to ensure a fast and coordinated response to future pandemics and infectious health threats.
HI³ is one of five national hubs established through the Canada Biomedical Research Fund (CBRF).
Research themes and cross-cutting capacities
Latest news
Canadian Hub for Health Intelligence and Innovation in Infectious Diseases awarded $72 million to strengthen talent development and health intelligence
NEWS | 6 May 2024
Four research programs in the Canadian Hub for Health Intelligence and Innovation in Infectious Diseases (HI3) have received $72 million in federal funding from the Canada Biomedical Research Fund (CBRF) and Biomedical Research Infrastructure Fund (BRIF), bolstering the country’s biomanufacturing capacity and readiness to respond to emerging health threats.
Support for HI3 and the four funded research programs through the CBRF and BRIF is part of a larger investment in Canada’s Biomanufacturing and Life Sciences Strategy.
Canada’s biomanufacturing and life sciences research hubs unite over shared vision to develop lifesaving vaccines and therapeutics
NEWS | 28 January 2024
On January 17, 2024, leadership teams representing Canada’s five biomanufacturing and life sciences research hubs came together to set the stage for a new wave of biomedical innovation in Canada. The goal of the session was to deepen collaboration across the five research hubs as they work to enhance Canada’s pandemic preparedness and biomanufacturing capacity, and to shape the hubs’ collective strategy for addressing the most pressing health challenges facing Canadians. The five hubs were announced in March 2023 as part of Canada's Biomanufacturing and Life Sciences Strategy.
Jen Gommerman in the Toronto Star—“We know there will be another pandemic. Here’s what four leading Canadian scientists are doing about it”
Toronto Star | 28 March 2023
Jen Gommerman, a professor of immunology at U of T’s Temerty Faculty of Medicine, worries momentum to ward off future pandemics, gained during the COVID years, will soon fade. Like most scientists, she agrees that lessons learned during the 2003 SARS outbreak were quickly forgotten.
“We can’t give up. We can’t just keep doing more of the same,” says Gommerman, who holds a Canada Research Chair in tissue-specific immunity. “We have to strive for better vaccines, the 2.0 versions of vaccines and therapeutics that will help us deal with what’s going to come next.
U of T home to new hub that will strengthen Canada’s pandemic preparedness and increase biomanufacturing capacity
U of T News | 4 March 2023
A new national hub focused on enhancing Canada’s ability to respond quickly, effectively and equitably to future pandemics has become a reality with $2 million in funding from the Canada Biomedical Research Fund.
Led and anchored by the University of Toronto, the Canadian Hub for Health Intelligence and Innovation in Infectious Diseases (HI3) is a collaborative, multi-disciplinary and multi-sector coalition of more than 80 partners. It will provide a powerful network to support a robust domestic pipeline of life-saving vaccines and therapeutics targeting existing and emerging infectious threats.
Government of Canada establishes new research hubs to accelerate Canada’s vaccine and therapeutics production
Canada.ca | 2 March 2023
Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, and the Honourable Jean-Yves Duclos, Minister of Health, announced an investment of $10 million in support of the creation of five multidisciplinary research hubs. This investment, made through Stage 1 of the integrated Canada Biomedical Research Fund (CBRF) and Biosciences Research Infrastructure Fund (BRIF) competition, will bolster research and talent development efforts led by the institutions, working in collaboration with their partners.